Why were Australian healthcare shares EX1 and RAC trending today?

• April 17, 2021 04:41 AM AEST
• Team Kalkine

Source: pickingpok, Shutterstock Summary The innovations and advancements in healthcare technology have been the key driving factors for economic progress. BrainChip has started manufacturing its neuromorphic processor chip for edge AI devices...

• April 16, 2021 02:41 PM AEST
• Team Kalkine

Source: smolaw, Shutterstock Summary A leader in human clinical therapeutics, Exopharm Limited today provided its quarterly update highlighting the growing interest in exosome medicines. The Company is investing in two interrelated technologie...

• April 16, 2021 12:05 PM AEST
• Team Kalkine

Source: Krisana Antharith, Shutterstock While the benchmark index, ASX200 was marginally down, two Australian healthcare penny stocks were on the move on the back of important announcements. Specialty pharmaceutical company Mayne Pharma Group Limite...

• April 15, 2021 07:18 PM AEST
• Team Kalkine

Source: DSkorynko, Shutterstock Summary Although Coinbase made a smashing debuted on NASDAQ, opening 4% higher than the reference price, the Company had humble beginnings. Co-founders Fred Ehrsam and Brian Armstrong met on Reddit and built the...

• April 15, 2021 01:02 PM AEST
• Team Kalkine

Source: REDPIXEL.PL, Shutterstock Summary Total Brain introduced discrete & continuous HRV functionality to its existing mental health self-monitoring and self-care platform. Electrochemical strips developer Universal Biosensors Inc has si...

• April 15, 2021 08:24 AM AEST
• Ashish

Oceania Healthcare Ltd (ASX:OCA, NZX:OCA) on Thursday announced that its non-underwritten retail offer was well received by shareholders and has closed oversubscribed. The company received over 5000 applications totalling nearly NZ$50 million for...

• April 14, 2021 04:55 PM AEST
• Team Kalkine

Source: Monster Ztudio, Shutterstock Summary Pharmaxis’ shares rose on the sale of Russian distribution rights for Bronchitol ®. The pharmaceutical research firm will get A$2 million distributor appointment fee. The drug maker is ra...

• April 13, 2021 01:21 PM AEST
• Team Kalkine

Source: Ratanapon Srisuneton, Shutterstock Summary Universal Biosensors has entered into exclusive agreements for the commercialisation and development of its biosensors. Avecho has received ethics approval to conduct an Australian Phase 1 cli...

• April 08, 2021 12:30 PM AEST
• Team Kalkine

Source: Guschenkova, Shutterstock Summary Dimerix Limited made substantial progress on the operational front during the third quarter. The Company focussed on clinical trials advancement to offer treatments worldwide for patients having seriou...

• April 08, 2021 08:28 AM AEST
• Ashish

s novel immunotherapy treatments for cancer, infectious and autoimmune diseases. Global biotechnology company Immutep Ltd (ASX:IMM) on Thursday announced that its lead product candidate eftilagimod alpha or efti had received fast track designati...